NeuroDiscovery AI

Solving trial recruitment, Unlocking real-world data, & Accelerating RWE generation.

[NeuroDiscovery AI @_NeuroDiscovery]

We have been selected for the @AnthropicAI x @awscloud #AgenticAIAccelerator 2026 an equity-free cohort for India's agentic AI startups.
This selection is a strong signal that the work is on the right track.
Learn More: https://t.co/oVfBMh29tr

[NeuroDiscovery AI @_NeuroDiscovery]

We are now a member of the @NVIDIAAI Inception program 🎉 Recognition for our work building AI for neurology drug discovery, clinical trials, and real-world evidence.

Excited for what this unlocks next #NVIDIAInception
Learn More: https://t.co/lgctLhkzht

[NeuroDiscovery AI @_NeuroDiscovery]

As we mark Alzheimer's & Brain Awareness Month this June, @BillGates declared we are entering "a golden age of Alzheimer's research."
🔗 Read Gates' piece: https://t.co/boFLEdirGl

[NeuroDiscovery AI @_NeuroDiscovery]

In the latest piece for @TheAIJournal1 , our CEO Vamsi Chandra Kasivajjala explains how purpose-built AI is reshaping pharma timelines, compressing patient screening from months to weeks.

Read the full article below! 👇
https://t.co/dhaQXX0WKz

[NeuroDiscovery AI @_NeuroDiscovery]

We are thrilled to officially launch NeuroTerminal, our neurology-first platform designed to accelerate clinical trial recruitment, real-world evidence, and therapy adoption.
📥 Read the full press release here: https://t.co/RiVwP0uIgv

[NeuroDiscovery AI @_NeuroDiscovery]

What a wrap at #AANAM 2026
From Phase 3 epilepsy breakthroughs to urgent conversations on access, disability & misinformation the future of neurology is being built now.
Grateful to @AANmember and our incredible alliance leaders for the vision and collaboration!

[NeuroDiscovery AI @_NeuroDiscovery]

Proud to share findings from our collaboration with @EliLillyandCo at the 19th International Conference on Alzheimer's and Parkinson's Diseases (ADPD) in Copenhagen, Denmark.
📊 Full poster available at: https://t.co/7noxJ4ZaiH

[NeuroDiscovery AI @_NeuroDiscovery]

We are honoured to have our NeuroVision (AI-neuroimaging tool), featured in the March 2026 issue of
@PracticalNeuro
📥 📷 Read the full article here: https://t.co/bZoj0yEQIT

[NeuroDiscovery AI @_NeuroDiscovery]

We are excited to head to @AANmember to discuss how an integrated intelligence strategy is the only way forward for neurology.

📍 Chicago
📅 April 18–22, 2026
Will you be there? Let’s talk.
🔗 Book your briefing slot here: https://t.co/f6tsTD5jhi

[NeuroDiscovery AI @_NeuroDiscovery]

"Our goal is to assist in meaningfully slowing, stopping, and/or reversing five major neurological conditions: Alzheimer's, frontotemporal dementia, migraine, multiple sclerosis, and Parkinson's."
- Vamsi Chandra Kasivajjala, CEO